Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|36|4076-4086

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.36, 2011-12, pp. : 4076-4086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging anti-HIV drugs

By De Clercq Erik  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 241-274

Informa Healthcare

Access to resources Recommend Favorite

Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1767-1783

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in the Design of Nucleoside Analogues as Anti-HIV Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 581-593

Bentham Science Publishers

Access to resources Recommend Favorite

RNA as A Target for Host Defense and Anti-HIV Drugs

By  

Current Drug Targets, Vol. 7, Iss. 12, 2006-12 ,pp. : 1607-1613

Bentham Science Publishers

Access to resources Recommend Favorite

Virostatics: A New Class of Anti-HIV Drugs

By  

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 233-241

Bentham Science Publishers

Access to resources Recommend Favorite